
Beijing Beier Bioengineering Co. , Ltd. , established in 1995, is a high-tech enterprise specializing in the research, development, production and sales of in vitro diagnostic reagents and supporting instruments. After years of continuous technological development, it has established seven major technology platforms: enzyme-linked immunoassay (ELISA), POCT (point-of-care testing), magnetic particle chemiluminescence, molecular diagnostics, mass spectrometry, medical instruments, and biochemical diagnostics. The company has built a complete industrial chain that includes reagents, instruments, quality control products, and consumables, offering a wide and comprehensive range of in vitro diagnostic products. The company has a TUV-certified ISO 13485 quality certification system, currently holds over 400 domestic medical registration certificates, including 3 drug registration certificates and more than 160 Class III medical device registration certificates. These certifications cover over ten product lines, including respiratory pathogens, prenatal and postnatal care, hepatitis viruses, EB virus, autoantibodies, thyroid hormones, sex hormones, tumor markers, cardiovascular diseases, and hypertension. The company has applied for more than 20 patents and has established a comprehensive system of independent intellectual property rights, demonstrating strong research and development capabilities. Beijing Beier Bioengineering Co. , Ltd. is committed to human health and focuses on exploring new areas of diagnostics. Currently, it has developed a diversified product platform and has the capability to provide comprehensive one-stop diagnostic solutions for clinical laboratories
Read More